Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Accolade Inc
(NQ:
ACCD
)
7.290
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Accolade Inc
< Previous
1
2
3
4
5
6
7
Next >
Accolade Analyst Finds Stock Attractively Valued Post Q3 Beat, T-5 Contract Win
January 10, 2023
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
Gainers
Via
Benzinga
Accolade's Return On Capital Employed Overview
January 10, 2023
Via
Benzinga
Accolade Earnings Preview
January 06, 2023
Via
Benzinga
Accolade Posts Narrower Quarterly Loss, Tightens Annual Sales Guidance
October 07, 2022
Via
Benzinga
Analyst Ratings for Accolade
October 04, 2022
Accolade (NASDAQ:ACCD) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Analyst Ratings for Accolade
September 07, 2022
Accolade (NASDAQ:ACCD) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Accolade Announces Results for Fiscal Third Quarter 2023
January 09, 2023
From
Accolade, Inc.
Via
GlobeNewswire
Earnings Scheduled For January 9, 2023
January 09, 2023
Companies Reporting Before The Bell • Commercial Metals (NYSE:CMC) is likely to report quarterly earnings at $1.96 per share on revenue of $2.20 billion.
Via
Benzinga
AMC Preferred Equity Units, Accolade And Some Other Big Stocks Moving Higher On Friday
December 23, 2022
U.S. stocks traded mixed, with the Dow Jones gaining over 50 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 24, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Here's Why Accolade Shares Are Trading Higher Today
July 01, 2022
Via
Benzinga
Accolade Announces Results for Fiscal Second Quarter 2023
October 06, 2022
From
Accolade, Inc.
Via
GlobeNewswire
Earnings Scheduled For October 6, 2022
October 06, 2022
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.52 per share on revenue of $2.85 billion.
Via
Benzinga
Accolade Earnings Preview
October 05, 2022
Accolade (NASDAQ:ACCD) is set to give its latest quarterly earnings report on Thursday, 2022-10-06. Here's what investors need to know before the announcement. Analysts estimate that Accolade will...
Via
Benzinga
Delta Air Lines To Rally Around 84%? Here Are 5 Other Price Target Changes For Tuesday
October 04, 2022
Raymond James raised Delta Air Lines, Inc. (NYSE: DAL) price target from $50 to $52. Raymond James analyst Savanthi Syth maintained a Strong Buy rating on the stock. Delta Air shares rose 0.7% to close...
Via
Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
October 04, 2022
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.
Via
Benzinga
Alphabet To $114? Plus This Analyst Predicts $145 For Disney
October 04, 2022
B of A Securities cut Alphabet Inc. (NASDAQ: GOOGL) price target from $125 to $114. Alphabet shares rose 1.9% to $100.50 in pre-market trading.
Via
Benzinga
Wells Fargo Slashes Price Target On This Stock By Over 71%, Also Check Out Other Major PT Changes Here
September 14, 2022
Wells Fargo cut the price target on Cabaletta Bio, Inc. (NASDAQ: CABA) from $14 to $4. Wells Fargo analyst Derek Archila maintained the stock with an Overweight rating. Cabaletta Bio shares gained 0.9%...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Upgrades
Via
Benzinga
Where Accolade Stands With Analysts
August 12, 2022
Over the past 3 months, 5 analysts have published their opinion on Accolade (NASDAQ:ACCD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
August 12, 2022
Via
Benzinga
Priority Health announces launch of new health navigation solution, PriorityGPS™
July 20, 2022
From
Priority Health
Via
Business Wire
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
July 08, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Via
Benzinga
U.S Stocks Turn Lower; Dow Tumbles Over 100 Points
July 01, 2022
U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 100 points on Friday.
Via
Benzinga
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
July 07, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.
Via
Benzinga
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
July 01, 2022
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.
Via
Benzinga
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
July 05, 2022
Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.
Via
Benzinga
10 Analysts Have This to Say About Accolade
July 01, 2022
Over the past 3 months, 10 analysts have published their opinion on Accolade (NASDAQ:ACCD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Accolade Moves Higher But Growth Is Slowing
July 01, 2022
Accolade (NASDAQ: ACCD) is certainly an interesting play on the health care space providing business and employee services geared toward helping clients navigate the cumbersome health benefits arena....
Via
MarketBeat
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.